Molecular basis of the catalytic differences among DT-diaphorase of human, rat, and mouse

Shiuan Chen, Richard Knox, Kebin Wu, Paulis S K Deng, Dujin Zhou, Mario Antonio Bianchet, Mario L Amzel

Research output: Contribution to journalArticle

Abstract

DT-diaphorase (EC 1.6.99.2), also referred to as NAD(P)H:(quinone- acceptor) oxidoreductase, is involved in the reductive activation process of several cytotoxic antitumor quinones and nitrobenzenes. It has been observed in our and other laboratories that the rat enzyme is significantly more effective in activating these drugs than the human and mouse enzymes. These results indicate that the available cytotoxic drugs are better substrates for the rat enzyme and are not the most ideal prodrugs for activation by DT- diaphorase in human tumors. In this study, using site-directed mutagenesis to replace residues in the rat enzyme with the human sequences and residues in the human enzyme with the rat sequences, we have found that residue 104 (Tyr in the rat enzyme and Gln in the human and mouse enzymes) is an important residue responsible for the catalytic differences between the rat and the human (and mouse) enzymes. With an exchange of a single amine acid, the rat mutant Y104Q behaved like the wild-type human enzyme, and the human mutant Q104Y behaved like the wild-type rat enzyme in their ability to reductively activate the cytotoxic drug CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide). The study also confirms the conclusion of the x-ray structural analysis of rat enzyme that residue 130 (Thr in the rat enzyme and Ala in the human and mouse enzymes) is positioned near the binding region of the nicotinamide portion of NAD(P)H. This structural information is very important for designing suitable drugs and approaches for human cancer chemotherapy mediated by DT-diaphorase.

Original languageEnglish (US)
Pages (from-to)1437-1439
Number of pages3
JournalJournal of Biological Chemistry
Volume272
Issue number3
DOIs
StatePublished - 1997

Fingerprint

NAD(P)H Dehydrogenase (Quinone)
Rats
Enzymes
Pharmaceutical Preparations
Nitrobenzenes
Chemical activation
Quinones
Mutagenesis
Chemotherapy
Niacinamide
Prodrugs
Site-Directed Mutagenesis
Structural analysis
NAD
Amines

ASJC Scopus subject areas

  • Biochemistry

Cite this

Molecular basis of the catalytic differences among DT-diaphorase of human, rat, and mouse. / Chen, Shiuan; Knox, Richard; Wu, Kebin; Deng, Paulis S K; Zhou, Dujin; Bianchet, Mario Antonio; Amzel, Mario L.

In: Journal of Biological Chemistry, Vol. 272, No. 3, 1997, p. 1437-1439.

Research output: Contribution to journalArticle

Chen, Shiuan ; Knox, Richard ; Wu, Kebin ; Deng, Paulis S K ; Zhou, Dujin ; Bianchet, Mario Antonio ; Amzel, Mario L. / Molecular basis of the catalytic differences among DT-diaphorase of human, rat, and mouse. In: Journal of Biological Chemistry. 1997 ; Vol. 272, No. 3. pp. 1437-1439.
@article{ad3c4057ebd94c5cb4041169f1788f14,
title = "Molecular basis of the catalytic differences among DT-diaphorase of human, rat, and mouse",
abstract = "DT-diaphorase (EC 1.6.99.2), also referred to as NAD(P)H:(quinone- acceptor) oxidoreductase, is involved in the reductive activation process of several cytotoxic antitumor quinones and nitrobenzenes. It has been observed in our and other laboratories that the rat enzyme is significantly more effective in activating these drugs than the human and mouse enzymes. These results indicate that the available cytotoxic drugs are better substrates for the rat enzyme and are not the most ideal prodrugs for activation by DT- diaphorase in human tumors. In this study, using site-directed mutagenesis to replace residues in the rat enzyme with the human sequences and residues in the human enzyme with the rat sequences, we have found that residue 104 (Tyr in the rat enzyme and Gln in the human and mouse enzymes) is an important residue responsible for the catalytic differences between the rat and the human (and mouse) enzymes. With an exchange of a single amine acid, the rat mutant Y104Q behaved like the wild-type human enzyme, and the human mutant Q104Y behaved like the wild-type rat enzyme in their ability to reductively activate the cytotoxic drug CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide). The study also confirms the conclusion of the x-ray structural analysis of rat enzyme that residue 130 (Thr in the rat enzyme and Ala in the human and mouse enzymes) is positioned near the binding region of the nicotinamide portion of NAD(P)H. This structural information is very important for designing suitable drugs and approaches for human cancer chemotherapy mediated by DT-diaphorase.",
author = "Shiuan Chen and Richard Knox and Kebin Wu and Deng, {Paulis S K} and Dujin Zhou and Bianchet, {Mario Antonio} and Amzel, {Mario L}",
year = "1997",
doi = "10.1074/jbc.272.3.1437",
language = "English (US)",
volume = "272",
pages = "1437--1439",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "3",

}

TY - JOUR

T1 - Molecular basis of the catalytic differences among DT-diaphorase of human, rat, and mouse

AU - Chen, Shiuan

AU - Knox, Richard

AU - Wu, Kebin

AU - Deng, Paulis S K

AU - Zhou, Dujin

AU - Bianchet, Mario Antonio

AU - Amzel, Mario L

PY - 1997

Y1 - 1997

N2 - DT-diaphorase (EC 1.6.99.2), also referred to as NAD(P)H:(quinone- acceptor) oxidoreductase, is involved in the reductive activation process of several cytotoxic antitumor quinones and nitrobenzenes. It has been observed in our and other laboratories that the rat enzyme is significantly more effective in activating these drugs than the human and mouse enzymes. These results indicate that the available cytotoxic drugs are better substrates for the rat enzyme and are not the most ideal prodrugs for activation by DT- diaphorase in human tumors. In this study, using site-directed mutagenesis to replace residues in the rat enzyme with the human sequences and residues in the human enzyme with the rat sequences, we have found that residue 104 (Tyr in the rat enzyme and Gln in the human and mouse enzymes) is an important residue responsible for the catalytic differences between the rat and the human (and mouse) enzymes. With an exchange of a single amine acid, the rat mutant Y104Q behaved like the wild-type human enzyme, and the human mutant Q104Y behaved like the wild-type rat enzyme in their ability to reductively activate the cytotoxic drug CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide). The study also confirms the conclusion of the x-ray structural analysis of rat enzyme that residue 130 (Thr in the rat enzyme and Ala in the human and mouse enzymes) is positioned near the binding region of the nicotinamide portion of NAD(P)H. This structural information is very important for designing suitable drugs and approaches for human cancer chemotherapy mediated by DT-diaphorase.

AB - DT-diaphorase (EC 1.6.99.2), also referred to as NAD(P)H:(quinone- acceptor) oxidoreductase, is involved in the reductive activation process of several cytotoxic antitumor quinones and nitrobenzenes. It has been observed in our and other laboratories that the rat enzyme is significantly more effective in activating these drugs than the human and mouse enzymes. These results indicate that the available cytotoxic drugs are better substrates for the rat enzyme and are not the most ideal prodrugs for activation by DT- diaphorase in human tumors. In this study, using site-directed mutagenesis to replace residues in the rat enzyme with the human sequences and residues in the human enzyme with the rat sequences, we have found that residue 104 (Tyr in the rat enzyme and Gln in the human and mouse enzymes) is an important residue responsible for the catalytic differences between the rat and the human (and mouse) enzymes. With an exchange of a single amine acid, the rat mutant Y104Q behaved like the wild-type human enzyme, and the human mutant Q104Y behaved like the wild-type rat enzyme in their ability to reductively activate the cytotoxic drug CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide). The study also confirms the conclusion of the x-ray structural analysis of rat enzyme that residue 130 (Thr in the rat enzyme and Ala in the human and mouse enzymes) is positioned near the binding region of the nicotinamide portion of NAD(P)H. This structural information is very important for designing suitable drugs and approaches for human cancer chemotherapy mediated by DT-diaphorase.

UR - http://www.scopus.com/inward/record.url?scp=0031026290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031026290&partnerID=8YFLogxK

U2 - 10.1074/jbc.272.3.1437

DO - 10.1074/jbc.272.3.1437

M3 - Article

C2 - 8999809

AN - SCOPUS:0031026290

VL - 272

SP - 1437

EP - 1439

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 3

ER -